Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRCA1 mutations contribute to cell motility and invasion by affecting its main regulators.

Literature DB >> 19098453

BRCA1 mutations contribute to cell motility and invasion by affecting its main regulators.

Amber Yasmeen, Wenchao Liu, Hafedh Dekhil, Amal Kassab, Raquel Aloyz, William D Foulkes, Ala-Eddin Al Moustafa.

Abstract

Entities: Gene Mutation

Mesh：

Substances：
BRCA1 Protein

Year: 2008 PMID： 19098453 DOI： 10.4161/cc.7.23.6993

Source DB: PubMed Journal: Cell Cycle ISSN： 1551-4005 Impact factor: 4.534

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.

Authors: Natalia Bednarz; Elke Eltze; Axel Semjonow; Michael Rink; Antje Andreas; Lennart Mulder; Juliane Hannemann; Margit Fisch; Klaus Pantel; Heinz-Ulrich G Weier; Krzysztof P Bielawski; Burkhard Brandt
Journal: Clin Cancer Res Date: 2010-06-30 Impact factor: 12.531

2. EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.

Authors: Tao Li; Jing Cai; Hui Ding; Linjuan Xu; Qiang Yang; Zehua Wang
Journal: Cancer Biol Ther Date: 2013-12-12 Impact factor: 4.742

3. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors: David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal: Cell Cycle Date: 2015 Impact factor: 4.534

7. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.

Authors: Alok De; Archana De; Ramratan Sharma; William Suo; Mukut Sharma
Journal: J Cancer Date: 2020-01-29 Impact factor: 4.207

7 in total

BRCA1 mutations contribute to cell motility and invasion by affecting its main regulators.

1. BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.

2. EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.

3. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Review 4. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

5. Cell-type-specific epigenomic variations associated with BRCA1 mutation in pre-cancer human breast tissues.

Review 6. BRCA1 and Metastasis: Outcome of Defective DNA Repair.

7. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.